BCL2 and gastric cancer: As shown in Figure 7A, western blots showed that B19 dose-dependently decreased the expression of anti-apoptotic proteins Bcl-2 and increased the expression of pro-apoptotic proteins Bax in three gastric cancer cell lines (SGC-7901, BGC-823 and KATO III).